Business Wire

Business Wire

Business Wire
GenSight Biologics Announces Publication of Results from LUMEVOQ® Phase I/IIa Clinical Trial REVEAL in BioDrugs

adminFebruary 15, 2021
0 1
February 15, 2021
0

Robert Karofsky Appointed Sole President UBS Investment Bank as Piero Novelli Retires
February 15, 2021
0

Hotel Nikko Narita Awarded Certification Under SGS Japan Cleaning and Disinfection Monitoring and Verification Process
February 15, 2021
0

Mitsubishi Electric Named to CDP Supplier Engagement Leaderboard
February 15, 2021
0

Mitsubishi Electric to Establish FA Products Service Center in Malaysia
February 15, 2021
0

Taiyo Pacific Partners L.P. Becomes Major Shareholder in ZENKOKU HOSHO CO., Ltd. with Stake Over 5%
February 15, 2021
0

nusilica Glass Foot File ‘yourb’ to Safely Remove Hard Foot Calluses
February 15, 2021
0

CORRECTING and REPLACING Compute Health Acquisition Corp. Announces Full Exercise of Over-Allotment Option and Closing of $862,500,000 Initial Public Offering
February 14, 2021
0

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Clover Health Investments, Corp.
February 14, 2021
0

Tyto Athene, LLC Is Dedicated in Their Support to AFCEA in Challenging Times, Vice President Fabian Plath Active Member of Two AFCEA Boards
February 14, 2021
0

Kerala CM inaugurates The Gender Park Campus after successful completion of global meet on gender equality
February 14, 2021
0

Blue Ocean Global certified as a Best Place To Work Company in UAE
February 14, 2021
0

AHF Endorses Biden Administration’s Call for China to Come Clean on Early COVID Data
February 14, 2021
0

National Condom Month: Shirin Peters, M.D. Offers 3 Steps to Combat Rising STI Rates Amid National Supply Shortage of STI Testing Kits
February 14, 2021
0

Business Development Director at Tyto Athene, LLC Begins 16th Year on Industrial Advisory Board at University of Massachusetts Dartmouth College of Engineering
February 13, 2021
0

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrated Superior Progression-Free Survival (PFS) and Overall Survival (OS) Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
February 13, 2021
0

Exelixis Highlights Positive Results for CABOMETYX® (cabozantinib) in Patients with Metastatic Papillary Renal Cell Carcinoma in SWOG S1500/PAPMET Study at ASCO GU
February 13, 2021
0

Morganti & Co, P.C., Announces Settlement Approval for FSD Pharma, Inc. Securities Class Action
February 13, 2021
0

Alchemy Partners Instpower to Enable Crypto Payments Across Global Network of Power Bank Sharing Stations
February 13, 2021
0

Vivendi will examine the distribution of 60% of UMG’s share capital and its listing by the end of the year
February 13, 2021
0

Paramount+ Invites Fans to Attend an Under-the-Sea Road Trip Adventure Drive-Through Experience and Exclusive Drive-In Screening for “The SpongeBob Movie: Sponge on the Run”
February 13, 2021
0

JPMorgan Chase Declares Preferred Stock Dividends
February 13, 2021
0

Tilray to Report 2020 Full Fiscal Year and Fourth Quarter Financial Results on February 17, 2021
February 13, 2021
0

Enable Midstream Announces Quarterly Distributions
February 13, 2021
0

Dr. Thomas Cannell, President and CEO of Sesen Bio, to Host Conference Call to Provide a Business Update
February 13, 2021
0

WESCO Announces Sale of Legacy Canada Datacom Business to Guillevin
February 13, 2021
0

Badger Meter Declares Regular Quarterly Dividend
February 13, 2021
0

Forward Air Announces Sale of Pool Distribution Business
February 13, 2021
0

HNI Corporation Fourth Quarter and Year-End Fiscal 2020 Results Conference Call
February 13, 2021
0

Lazard Growth Acquisition Corp. I Announces Closing of Initial Public Offering and Exercise in Full of Underwriter’s Option to Purchase Additional Units